MOLN

MOLECULAR PARTNERS AG

• TipRanks·6d ago

  Molecular Partners Sets 2026 AGM, Nominates Clare Fisher to Board as Long-Serving Director Steps Down

• Reuters·6d ago

  Molecular Partners schedules annual shareholder meeting, nominates Clare Fisher to board

• Reuters·03/23 13:00

  Molecular Partners proposes Clare Fisher for board election at April 14, 2026 AGM

• Reuters·03/23 13:00

  MOLECULAR PARTNERS PUBLISHES INVITATION TO ANNUAL GENERAL MEETING 2026 AND PROPOSES CLARE FISHER FOR ELECTION TO ITS BOARD OF DIRECTORS

• Reuters·03/23 12:55

  Molecular Partners AG announced its 2026 annual general meeting agenda and compensation proposals of up to CHF 4.46 million

• TipRanks·03/19 13:20

  Analysts Offer Insights on Healthcare Companies: ProKidney (PROK), Molecular Partners (MOLN) and Bristol-Myers Squibb (BMY)

• Benzinga·03/19 06:35

  Molecular Partners Highlights Radio-DARPin Platform's Interchangeability Of Alpha-Isotopes Including 212Pb And 225Ac In New Preclinical Data

• Reuters·03/19 06:00

  Molecular Partners to present new Radio-DARPin isotope data at Global Radiopharmaceuticals Development Summit

• Reuters·03/17 20:30

  Molecular Partners to Present Three Posters at AACR 2026 Annual Meeting

• TipRanks·03/16 15:50

  3 Best Stocks to Buy Today, 3/16/2026, According to Top Analysts

• Benzinga·03/16 11:18

  HC Wainwright & Co. Reiterates Buy on Molecular Partners, Maintains $13 Price Target

• TipRanks·03/16 10:26

  Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target

• TipRanks·03/16 05:45

  Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating

• TipRanks·03/13 17:39

  Molecular Partners Posts 2025 Results, Advances Radio-DARPins and Oncology Pipeline

• TipRanks·03/13 16:15

  Buy Recommendation on Molecular Partners: Advancing Radio-DARPin Platform, Strategic Isotope Collaboration, and Cash Runway Through 2028 Underpin Attractive Risk‑Reward